Showing results (701-710 of 1,191) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|September 18, 2018
A case study of an adaptive design for a clinical trial with 2 doses and 2 endpoints in a rare disease areaHui Quan, Yi Xu, Yixin Chen, et al.Pharmaceutical Statistics|August 29, 2018
Phase 3 adaptive trial design options in treatment of complicated urinary tract infectionKert Viele, Linda M Mundy, Robert B Noble, et al.Pharmaceutical Statistics|May 6, 2017
Enhancement of the adaptive signature design for learning and confirming in a single pivotal trialGu MiPharmaceutical Statistics|April 11, 2018
Practical experiences of adopting assurance as a quantitative framework to support decision making in drug developmentAdam Crisp, Sam Miller, Douglas Thompson, et al.Pharmaceutical Statistics|April 7, 2018
An evaluation of the trimmed mean approach in clinical trials with dropoutMing-Dauh Wang, Jiajun Liu, Geert Molenberghs, et al.Pharmaceutical Statistics|November 21, 2017
A case study in identifying targeted patients population in major depressive disorder by enhanced enrichment designPeter Zhang, Kevin Carroll, Mary Hobart, et al.Pharmaceutical Statistics|June 21, 2021
A mixed effects model for analyzing area under the curve of longitudinally measured biomarkers with missing dataLuoxi Shi, Dorothy K Hatsukami, Joseph S Koopmeiners, et al.Pharmaceutical Statistics|May 7, 2022
Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observationsSangbum Choi, Taehwa Choi, Hye-Young Lee, et al.Pharmaceutical Statistics|December 29, 2018
Properties of the weighted log-rank test in the design of confirmatory studies with delayed effectsJosé L Jiménez, Viktoriya Stalbovskaya, Byron JonesPharmaceutical Statistics|February 24, 2018
Bayesian joint modelling of benefit and risk in drug developmentMaria J Costa, Thomas DruryPageof 120